BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moschini M, Xylinas E, Zamboni S, Mattei A, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan UN, Rosenberg JE, Bellmunt J, Galsky MD, Montorsi F, Necchi A; RISC Investigators. Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database. Eur Urol Oncol 2020;3:94-101. [PMID: 31307962 DOI: 10.1016/j.euo.2019.06.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Koerber SA, Fink CA, Dendl K, Schmitt D, Niegisch G, Mamlins E, Giesel FL. [Imaging of oligometastatic disease in selected urologic cancers]. Urologe A 2021;60:1561-9. [PMID: 34850260 DOI: 10.1007/s00120-021-01708-0] [Reference Citation Analysis]
2 Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn BWGV, Zigeuner R, Shariat SF. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur Urol 2021;79:62-79. [PMID: 32593530 DOI: 10.1016/j.eururo.2020.05.042] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 34.0] [Reference Citation Analysis]
3 Moschini M. From Basic Science to Clinical Research to Develop New Solutions to Improve Diagnoses and Treatment of Bladder Cancer Patients. J Clin Med 2020;9:E2373. [PMID: 32722358 DOI: 10.3390/jcm9082373] [Reference Citation Analysis]
4 Zhang X, Wang P, Qi K, Qiao Q, Jiang Y. The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma. Cancer Med 2021;10:8079-90. [PMID: 34647688 DOI: 10.1002/cam4.4327] [Reference Citation Analysis]
5 Mizuno T, Kamai T, Tsuzuki T, Nishihara D, Kijima T, Arai K, Yoshida KI. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma. Cancer Immunol Immunother 2021. [PMID: 34275008 DOI: 10.1007/s00262-021-03011-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Mistretta FA, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI. The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder. Am J Clin Oncol 2020;43:567-74. [PMID: 32467527 DOI: 10.1097/COC.0000000000000704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang P, Zang S, Li G, Qu W, Li S, Qiao Q, Jiang Y. The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern. Cancer Med 2020;9:9293-302. [PMID: 33107706 DOI: 10.1002/cam4.3560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li K, Yang X, Zhuang J, Cai L, Han J, Yu H, Zhou Z, Lv J, Feng D, Yuan B, Wu Q, Li P, Cao Q, Lu Q. External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center. BMC Urol 2022;22:41. [PMID: 35313884 DOI: 10.1186/s12894-022-00987-9] [Reference Citation Analysis]
9 Pollock G, Hsu CH, Batai K, Lee BR, Chipollini J. Postoperative and Survival Outcomes After Cytoreductive Surgery in the Treatment of Metastatic Upper Tract Urothelial Carcinoma. Urology 2021;153:244-9. [PMID: 33482133 DOI: 10.1016/j.urology.2021.01.017] [Reference Citation Analysis]
10 Lin W, Lin M, Yang Y, Chen W, Huang C, Chen M, Wu C. Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma. Front Surg 2022;9:903123. [DOI: 10.3389/fsurg.2022.903123] [Reference Citation Analysis]
11 Wei Y, Amend B, Todenhöfer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. Int J Mol Sci 2022;23:6305. [PMID: 35682984 DOI: 10.3390/ijms23116305] [Reference Citation Analysis]
12 Necchi A, Marandino L, Raggi D, Bandini M, Gallina A, Moschini M, Briganti A, Montorsi F. Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? Eur Urol 2021;79:713-6. [PMID: 32861574 DOI: 10.1016/j.eururo.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Paciotti M, Nguyen DD, Modonutti D, Haeuser L, Lipsitz S, Mossanen M, Kibel AS, Lughezzani G, Trinh QD, Cole AP. Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma. Urol Oncol 2021;39:436.e1-436.e10. [PMID: 33736978 DOI: 10.1016/j.urolonc.2021.01.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kobayashi T, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Ogawa O, Kitamura H, Nishiyama H; Japan Urological Oncology Group. Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab. Cancer Sci 2021;112:760-73. [PMID: 33283385 DOI: 10.1111/cas.14762] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
15 Lim AH, Narayan VM, Navai N. The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial. Eur Urol Oncol 2020;3:102-3. [PMID: 31501083 DOI: 10.1016/j.euo.2019.08.006] [Reference Citation Analysis]
16 Cinque A, Capasso A, Vago R, Floris M, Lee MW, Minnei R, Trevisani F. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer? Int J Mol Sci 2022;23:2602. [PMID: 35269744 DOI: 10.3390/ijms23052602] [Reference Citation Analysis]
17 Muilwijk T, Akand M, Van der Aa F, Dumez H, De Meerleer G, Van Raemdonck D, De Leyn P, Van Poppel H, Albersen M, Joniau S. Metastasectomy of oligometastatic urothelial cancer: a single-center experience. Transl Androl Urol 2020;9:1296-305. [PMID: 32676413 DOI: 10.21037/tau-19-624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tao L, Pan X, Zhang L, Wang J, Zhang Z, Zhang L, Liang C. Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study. Front Oncol 2020;10:586458. [PMID: 33194738 DOI: 10.3389/fonc.2020.586458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Seles M, Mischinger J, Zigeuner R. Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con. Eur Urol Open Sci 2021;32:35-7. [PMID: 34522903 DOI: 10.1016/j.euros.2021.08.003] [Reference Citation Analysis]
20 Rouprêt M, Audenet F, Roumiguié M, Pignot G, Masson-Lecomte A, Compérat E, Houédé N, Larré S, Brunelle S, Xylinas E, Neuzillet Y, Méjean A. [French ccAFU guidelines - update 2020-2022: upper urinary tract urothelial carcinoma]. Prog Urol 2020;30:S52-77. [PMID: 33349430 DOI: 10.1016/S1166-7087(20)30750-8] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR. Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. BJU Int 2021. [PMID: 34597472 DOI: 10.1111/bju.15603] [Reference Citation Analysis]
22 Lim AH, Westerman ME, Korokovic A, Matulay JT, Narayan VM, Navai N. Efficacy of Surgery on the Primary Tumour in Patients with Metastatic Bladder Cancer: A Comprehensive Review. BLC 2022. [DOI: 10.3233/blc-211529] [Reference Citation Analysis]
23 Thouvenin J, Martínez Chanzá N, Alhalabi O, Lang H, Tannir NM, Barthélémy P, Malouf GG. Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions. Cancers (Basel) 2021;13:4341. [PMID: 34503152 DOI: 10.3390/cancers13174341] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]